{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T13:32:26Z","timestamp":1794835946499,"version":"4.9.1"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,21]]},"abstract":"<jats:p>Anthracyclines have been one of the most important therapeutic methods in breast cancer therapy for decades. However, serious long-term toxicities, especially cardiotoxicity limits the continuous usage of anthracyclines, hence affects long term prognosis. Early detection of myocardial dysfunction during treatment is critical but challenging. Two-dimensional speckle tracking echocardiography (2D-STE) is a non-Doppler technique that can assess deformation and strain by tracking displacement of acoustic markers in the myocardium. This study aims to compare the sensitivity and precision between 2D-STE and traditional echocardiography on monitoring the left ventricular function in patients with breast cancer after anthracyclines therapy, which is the key indicator for evaluating myocardial changes. Thirty-three patients with breast cancer were recruited from February 2019 to December 2019. All patients were treated with 4 cycles anthracycline. 2D-STE and conventional echocardiography were performed on each patient. Two-dimensional echocardiographic examination was used to collect data interventricular septum diameter (IVSD), end-diastolic left ventricular posterior wall diameter (LVPWD), left ventricular end-diastolic diameter (LVEDD) and left ventricular systole on the parasternal left ventricular long axis view. The final diameter (left ventricular end-systolic diameter [LVESD]) and the left ventricular short axis shortening rate (LVFS) was measured by M-type. The two-plane Simpson\u2019s method was used to measure left ventricular end-diastolic volume (LVEDV) and end-systolic volume (left ventricular end-systolic volume [LVESV]) to obtain left ventricular ejection fraction (LVEF). Two-dimensional speckle tracking imaging technical indicator includes left ventricular global longitudinal strain (LVGLS), subendocardial myocardial longitudinal strain (LVGLS-Endo) and epicardial myocardial longitudinal strain (LVGLS-Epi). The correlation between 2-dimensional speckle tracking imaging and conventional ultrasound parameters were analyzed. Compared with baseline (T0), the systolic function parameter LVEF was significantly changed after four cycle chemotherapy (T4) (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .05). However, the conventional echocardiographic parameters including IVSD, LVPWD, LVEDD, LVESD, LVEDV, and LVESV were not statistically significant (<jats:italic toggle=\"yes\">P<\/jats:italic> &gt; .05). Meanwhile, the two-dimensional strain parameters LVGLS, LVGLS-Endo, and LVGLS-Epi were statistically significant after T2 and T4 cycle chemotherapy (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .01).The two-dimensional strain parameter GLS has higher accuracy and sensitivity for monitoring left ventricular insufficiency caused by anthracycline therapy when compared with traditional echocardiography.<\/jats:p>","DOI":"10.1097\/md.0000000000031084","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T19:03:43Z","timestamp":1666638223000},"page":"e31084","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Two-dimensional speckle tracking echocardiography, a powerful method for the evaluation of anthracyclines induced left ventricular insufficiency"],"prefix":"10.1097","volume":"101","author":[{"given":"Wei","family":"Chen","sequence":"first","affiliation":[{"name":"The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Jiao","sequence":"additional","affiliation":[{"name":"The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Li","sequence":"additional","affiliation":[{"name":"The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0954-2386","authenticated-orcid":false,"given":"Ruoling","family":"Han","sequence":"additional","affiliation":[{"name":"The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1159\/000441818","article-title":"Current status and future projections of breast cancer in Asia.","volume":"10","author":"Fan","year":"2015","journal-title":"Breast Care (Basel)"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the molecular basis of doxorubicin-induced cardiotoxicity.","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat Med"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4250\/jcu.2018.26.1.1","article-title":"Diagnosis, treatment, and prevention of cardiovascular toxicity related to anti-cancer treatment in clinical practice: an opinion paper from the working group on cardio-oncology of the Korean society of echocardiography.","volume":"26","author":"Kim","year":"2018","journal-title":"J Cardiovasc Ultrasound"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.5603\/KP.2016.0156","article-title":"[2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines].","volume":"74","author":"Zamorano","year":"2016","journal-title":"Kardiol Pol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/echo.14252","article-title":"Use of echocardiography to monitor myocardial damage during anthracycline chemotherapy.","volume":"36","author":"Anqi","year":"2019","journal-title":"Echocardiogr"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1159\/000356850","article-title":"Evaluation of cardiotoxicity via speckle-tracking echocardiography in patients treated with anthracyclines.","volume":"36","author":"Dogru","year":"2013","journal-title":"Onkologie"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/ejechocard\/jer021","article-title":"Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE\/EAE consensus statement on methodology and indications endorsed by the Japanese society of echocardiography.","volume":"12","author":"Mor-Avi","year":"2011","journal-title":"Eur J Echocardiogr"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ejhf.8","article-title":"Two-dimensional speckle tracking echocardiography combined with high-sensitive cardiac troponin T in early detection and prediction of cardiotoxicity during epirubicine-based chemotherapy.","volume":"16","author":"Kang","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12574-017-0344-6","article-title":"Echocardiographic evaluation of cardiac function after cancer chemotherapy.","volume":"16","author":"Negishi","year":"2018","journal-title":"J Echocardiogr"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.echo.2009.10.004","article-title":"Circumferential and longitudinal strain in 3 myocardial layers in normal subjects and in patients with regional left ventricular dysfunction.","volume":"23","author":"Leitman","year":"2010","journal-title":"J Am Soc Echocardiogr"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.jacc.2006.07.048","article-title":"Myocardial strain and torsion quantified by cardiovascular magnetic resonance tissue tagging: studies in normal and impaired left ventricular function.","volume":"48","author":"G\u00f6tte","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/pbc.20352","article-title":"Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: implications for screening and prevention.","volume":"44","author":"Adams","year":"2005","journal-title":"Pediatr Blood Cancer"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031084","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:41:54Z","timestamp":1746333714000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":13,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000031084","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,21]]}}}